Free Trial

China Pharma (CPHI) Competitors

China Pharma logo
$1.90 +0.04 (+2.09%)
Closing price 07/25/2025 03:56 PM Eastern
Extended Trading
$1.90 -0.01 (-0.47%)
As of 07/25/2025 06:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CPHI vs. DARE, AYTU, LSTA, PULM, GDTC, ELEV, NAII, CVKD, CMMB, and RLMD

Should you be buying China Pharma stock or one of its competitors? The main competitors of China Pharma include Dare Bioscience (DARE), Aytu BioPharma (AYTU), Lisata Therapeutics (LSTA), Pulmatrix (PULM), CytoMed Therapeutics (GDTC), Elevation Oncology (ELEV), Natural Alternatives International (NAII), Cadrenal Therapeutics (CVKD), Chemomab Therapeutics (CMMB), and Relmada Therapeutics (RLMD). These companies are all part of the "pharmaceutical products" industry.

China Pharma vs. Its Competitors

China Pharma (NYSE:CPHI) and Dare Bioscience (NASDAQ:DARE) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, media sentiment, risk, analyst recommendations, dividends, valuation and profitability.

6.7% of Dare Bioscience shares are held by institutional investors. 17.3% of China Pharma shares are held by insiders. Comparatively, 4.0% of Dare Bioscience shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Dare Bioscience had 2 more articles in the media than China Pharma. MarketBeat recorded 3 mentions for Dare Bioscience and 1 mentions for China Pharma. China Pharma's average media sentiment score of 1.25 beat Dare Bioscience's score of 0.63 indicating that China Pharma is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
China Pharma
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Dare Bioscience
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Dare Bioscience has a net margin of 0.00% compared to China Pharma's net margin of -85.56%. Dare Bioscience's return on equity of 0.00% beat China Pharma's return on equity.

Company Net Margins Return on Equity Return on Assets
China Pharma-85.56% -63.93% -31.42%
Dare Bioscience N/A N/A -8.14%

China Pharma has higher revenue and earnings than Dare Bioscience.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
China Pharma$4.30M1.45-$3.08MN/AN/A
Dare Bioscience$10K2,274.45-$4.05M-$0.17-15.12

China Pharma has a beta of 0.79, suggesting that its share price is 21% less volatile than the S&P 500. Comparatively, Dare Bioscience has a beta of 1.14, suggesting that its share price is 14% more volatile than the S&P 500.

Dare Bioscience has a consensus price target of $12.00, indicating a potential upside of 366.93%. Given Dare Bioscience's stronger consensus rating and higher probable upside, analysts clearly believe Dare Bioscience is more favorable than China Pharma.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
China Pharma
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Dare Bioscience
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

Summary

Dare Bioscience beats China Pharma on 10 of the 14 factors compared between the two stocks.

Get China Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for CPHI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CPHI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CPHI vs. The Competition

MetricChina PharmaPharmaceutical IndustryMedical SectorNYSE Exchange
Market Cap$6.17M$786.26M$5.70B$21.04B
Dividend YieldN/A4.84%4.58%3.59%
P/E RatioN/A1.4428.4128.45
Price / Sales1.4525.35432.3171.70
Price / CashN/A19.5636.2222.92
Price / Book2.726.918.674.68
Net Income-$3.08M-$4.17M$3.25B$995.51M
7 Day Performance7.94%1.01%4.25%1.65%
1 Month Performance9.68%3.65%10.51%4.54%
1 Year Performance-92.38%9.83%35.68%10.00%

China Pharma Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CPHI
China Pharma
0.4773 of 5 stars
$1.90
+2.1%
N/A-92.4%$6.17M$4.30M0.00250Positive News
Gap Down
DARE
Dare Bioscience
1.7891 of 5 stars
$2.61
-2.6%
$12.00
+359.8%
-28.6%$23.10M$25.91K-15.3530Gap Up
AYTU
Aytu BioPharma
4.1357 of 5 stars
$2.56
+8.0%
$10.00
+290.6%
-2.6%$22.98M$81.66M-3.56160
LSTA
Lisata Therapeutics
2.944 of 5 stars
$2.64
+2.3%
$23.50
+790.2%
-21.3%$22.76M$1M-1.1530Gap Down
PULM
Pulmatrix
0.8547 of 5 stars
$6.08
+0.2%
N/A+166.4%$22.19M$1.92M-1.8220
GDTC
CytoMed Therapeutics
1.4606 of 5 stars
$2.02
+1.0%
$5.00
+147.5%
-5.3%$22.10M$69.50K0.00N/AUpcoming Earnings
ELEV
Elevation Oncology
2.8522 of 5 stars
$0.37
-2.1%
$3.39
+827.6%
N/A$21.62MN/A-0.4540High Trading Volume
NAII
Natural Alternatives International
1.1094 of 5 stars
$3.47
+3.3%
N/A-35.7%$21.45M$113.80M-2.50290
CVKD
Cadrenal Therapeutics
3.092 of 5 stars
$10.81
+0.2%
$32.00
+196.0%
N/A$21.30MN/A-1.174Positive News
CMMB
Chemomab Therapeutics
3.0925 of 5 stars
$1.12
+1.8%
$8.50
+658.9%
-8.4%$21.12MN/A-1.4720Gap Up
RLMD
Relmada Therapeutics
4.8099 of 5 stars
$0.63
+1.9%
$5.00
+699.4%
-84.0%$20.76MN/A-0.2510Positive News
Gap Down

Related Companies and Tools


This page (NYSE:CPHI) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners